Re: Neoadjuvant chemotherapy for advanced ovarian cancer. Who really benefits?

Autor: Pather S; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia., Tejada Berges T; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia., Saidi S; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia., Carter J; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia.
Jazyk: angličtina
Zdroj: The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2018 Dec; Vol. 58 (6), pp. E25-E26.
DOI: 10.1111/ajo.12827
Databáze: MEDLINE